In collaboration with our academic partner we launch the production of Endolysin 812, a highly active killer enzyme of the major pathogen S. aureus including MRSA strain. It selectively kills only S. aureus cells leaving other commensal bacteria intact.
We launch production of genetically enhanced form of TEV protease with higher activity and thermal stability. This enzyme shows superior activity/costs ration and is available also in bulk quantities upon request.
We offer higly active nonspecific nuclease (Benzonase® or Supernuclease® equivalent) from Serratia marcescens for DNA and RNA removal and viscosity reduction of cell lysates.
„Our vaccine development is greatly enhanced with the help of highly immunoreactive antigens from Protean.“V. Vrzal, Deputy CEO, Bioveta a.s. More reviews →